---
title: "HSCS.US (HSCS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HSCS.US/news.md"
symbol: "HSCS.US"
name: "HSCS.US"
parent: "https://longbridge.com/en/quote/HSCS.US.md"
datetime: "2026-03-12T14:20:28.270Z"
locales:
  - [en](https://longbridge.com/en/quote/HSCS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HSCS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HSCS.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/HSCS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/HSCS.US/news.md)


# HSCS.US (HSCS.US) — Related News

### [University of West England Adopts HeartSciences MyoVista ECG Platform](https://longbridge.com/en/news/274981993.md)
*2026-02-05T13:30:37.000Z*
### [HeartSciences Wins Cibolo Health Endorsement for MyoVista Insights ECG Platform](https://longbridge.com/en/news/274158425.md)
*2026-01-29T13:30:34.000Z*
### [Heart Test Laboratories: AI-Driven Cardiology Platform Nearing Regulatory Milestones Supports Upside and Buy Rating](https://longbridge.com/en/news/270724381.md)
*2025-12-24T12:05:17.000Z*
> Ascendiant analyst Lucas Ward maintains a Buy rating on Heart Test Laboratories (HSCS) due to operational progress and u

### [HeartSciences | 8-K: FY2026 Q2 Revenue: USD 0](https://longbridge.com/en/news/269770882.md)
*2025-12-15T21:19:04.000Z*
### [HeartSciences | 10-Q: FY2026 Q2 Revenue: USD 2.419 K](https://longbridge.com/en/news/269770325.md)
*2025-12-15T21:13:58.000Z*
### [Heart Test Laboratories Announces Successful Regulation A Offering](https://longbridge.com/en/news/259712924.md)
*2025-10-01T21:48:25.000Z*
> Heart Test Laboratories, Inc. (HSCS) announced a successful Regulation A Offering, generating $6.7 million in gross proc

### [Heart Test Laboratories Regains Nasdaq Compliance](https://longbridge.com/en/news/257795006.md)
*2025-09-17T21:22:02.000Z*
> Heart Test Laboratories, Inc. (HSCS) has regained compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement afte

### [HeartSciences | 10-Q: FY2026 Q1 Revenue: USD 1.9 K](https://longbridge.com/en/news/256983525.md)
*2025-09-11T20:06:23.000Z*
### [HeartSciences | 10-K: FY2025 Revenue: USD 4 K](https://longbridge.com/en/news/250020867.md)
*2025-07-24T20:06:46.000Z*
### [HeartSciences | 10-K: FY2024 Revenue: USD 18.6 K](https://longbridge.com/en/news/243364847.md)
*2025-06-06T02:00:30.000Z*